RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

RVL Pharmaceuticals plc

AbbVie engages in pharmaceutical research and development to provide innovative solutions for patients.

AbbVie

Allergan Aesthetics offers aesthetic products and services, including injectable treatments and medical devices. It is self-described as being part of AbbVie.

Allergan Aesthetics

BTL provides advanced technologies for skin, fat, muscle, cellulite, and wrinkles treatments, partnering with medical professionals across various specialties to offer aesthetic and health-related solutions.

BodybyBTL

RVL Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing eyecare and medical aesthetics products.

RVL Pharmaceuticals

RVL Pharmaceuticals | 9,832 followers on LinkedIn. RVL Pharmaceuticals plc is a specialty pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. The Company is currently commercializing UPNEEQ® (oxymetazoline hydrocholoride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. UPNEEQ is the first non-surgical treatment option approved by the FDA for acquired blepharoptosis.

National Search Consultant @ Hudson RPO | Currently supporting RVL Pharmaceuticals

Dierdre Hutton

Vice President Education & Scientific Affairs, PRN Vision Group; Optometric Physician/Partner Moorestown Eye Associates

Kimberly Friedman, OD FAAO

Jennifer (Alvarez) Hanlon

Senior Learning and Development Professional

Nancy Barnes, CPTD

Upneeq® Wins 2024 Shape Skin Award, "Best for Lift", in the Professional Treatment Category https://lnkd.in/eRVjapCV

🌟 Exciting Opportunity Alert! 🌟 We’re on the lookout for an Accounting Manager to join our dynamic team in Bridgewater, NJ! This hybrid role is perfect for a seasoned professional ready to lead our financial operations with a focus on product revenue and inventory management. Qualifications: 8+ years of public and private accounting experience. Bachelor’s degree in accounting and CPA license. Strong understanding of US GAAP, particularly ASC606. Proficient in Excel and experience with ERP systems (NetSuite a plus). If you’re ready to take your career to the next level and make a strategic impact in our organization, we’d love to hear from you! 📩 Apply now at bit.ly/RVLCareers or share this opportunity with someone who might be interested! #AccountingJobs #Hiring #AccountingManager #Finance #CareerOpportunity JoAnn Bonante Katerina Gembarski CPA/MBA

This National Aesthetician Day, we share our care for those who work alongside patients and dermatologists alike to keep us looking and feeling the most comfortable in our skin.

Preventing blindness and other vision impairments starts with consistent and thorough eye care, which is why, on World Sight Day, we take time to prioritize the gift of sight.

On this Patriot Day, we honor the memory of those we lost on 9/11 and pay tribute to the heroes who showed extraordinary courage. May we continue to stand united and remember the strength that brings us together. #PatriotDay #NeverForget #HonorAndRemember

🚀 Join Our Team as an Inside Sales Representative! 🚀 We’re looking for a motivated Inside Sales Representative to represent Upneeq® and Elevate in the Med Spa and cosmetic surgery sectors. In this role, you’ll drive product adoption, manage relationships, and deliver remote training to practices. Requirements: Bachelor’s Degree 1-3 years of inside sales experience (pharmaceutical/B2B preferred) Strong remote selling skills Ability to thrive in a fast-paced, results-oriented environment If you’re ready to make an impact and excel in a dynamic role, apply now at bit.ly/RVLCareers or share with your network! #InsideSales #SalesJobs #AestheticsSales #JoinOurTeam #RemoteSelling Andrea Lee Danielle Scandone

🚀Exciting Opportunity Alert! 🚀 We're on the lookout for a dynamic Accounting Manager to join our corporate accounting team and make a significant impact on our organization! 🌟 As a key player in our accounting operations, you'll be instrumental in overseeing the financial health of a major subsidiary. Your role will encompass: 📊 Ensuring accurate financial reporting in line with US GAAP 🗂️ Maintaining compliance with Federal, State, and Local regulations 🔧 Driving operational efficiency across accounting processes Requirements: 8+ years of accounting experience CPA License Advanced Excel skills ERP experience preferred (NetSuite a plus) Ready to elevate your career? Apply now at bit.ly/RVLCareers or share with your network! #Accounting #FinanceJobs #AccountingManager #CareerOpportunity #JoinOurTeam #HybridWork Katerina Gembarski CPA/MBA

We take this Labor Day to thank our team for all the work they contribute towards RVL's values and priorities. Job well done, and in return, we wish them and everyone else a recuperative Monday off! #LaborDay24

We at RVL wish to recognize the dedication, determination, and courage that humanitarian aid workers embody, today and year-round. #WorldHumanitarianDay

Metric
Company Name	RVL Pharmaceuticals plc	AbbVie	Allergan Aesthetics	BodybyBTL
Symbol	RVLP
MSH ID	COM:RVLPHARMA	AR:COM:ABBVIE	COM:ALLERGANAESTHETICS	COM:BTLAESTHETICS
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Biotechnology	Pharmaceuticals	Cosmetics and Aesthetic Treatments	Medical Technology
Country	US	AR	US	US
Stage
Employee Count	125
Website	rvlpharma.com	abbvie.com.ar	allerganaesthetics.com	btlaesthetics.com
LinkedIn	rvl-pharmaceuticals-inc		allergan-aesthetics
Founders

Metric
Market Cap	3.14M
Enterprise Value
Monthly Web Traffic	1.19K	24.70K
Web Traffic Growth	-0.82	2.20
Valuation
Raised Capital

Metric
Revenue	49.72M
Revenue (LTM)
Revenue (NTM)
Gross Profit	40.27M
EBITDA	-36.19M
Operating Income	-45.68M
Net Income	-51.69M
EPS	-0.58
Diluted EPS	-0.58
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.75
Operating Profit Margin	-1.56
EBITDA Margin	-0.73
Net Profit Margin	-1.85
Return on Equity	-1.55
Return on Assets	-0.80
Return on Capital Employed	-3.38

COM:RVLPHARMA

RVL Pharmaceuticals

Last Close

0.04

20/10 20:00

Market Cap

3.14M

Beta: -

Volume Today

63.96M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-0.04
P/B Ratio	0.17
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.09
EV Multiple	0.99

Metric
Days Sales Outstanding	19.10
Days Payables Outstanding	98.98
Days Inventory Outstanding	53.05
Operating Cycle	72.15
Cash Conversion Cycle	-26.83
Asset Turnover	0.43

Metric
Operating Cash Flow	-37.81M
Free Cash Flow	-38.56M
Cash Flow to Debt	-0.76
Operating Cash Flow/Sales	-1.20
Free Cash Flow Yield	-15.11

Metric
Cash & Equivalents	44.54M
Accounts Receivable	-898K
Inventory	784K
Goodwill	55.85M
Debt to Capitalization	0.78
Debt to Assets	0.68
Current Ratio	0.38
Quick Ratio	0.31

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.06
R&D to Revenue	0.08
SG&A to Revenue